/logo.svgIpoTec


Anthem Biosciences Ipo


Objects of the Issue

  • The Company will not receive any proceeds from the Offer (the “Offer Proceeds”) and all the Offer Proceeds will be received by the Selling Shareholders after deduction of Offer related expenses and relevant taxes thereon, to be borne by the respective Selling Shareholders.

Anthem Biosciences IPO Review

  • IPO Watch – May Apply

  • Canara Bank –

  • DRChoksey FinServ –

  • Emkay Global –

  • Hem Securities –

  • IDBI Capital –

  • Marwadi Shares –

  • Nirmal Bang –

  • SBICAP Securities –

  • Sharekhan –

  • SMC Global –

  • Sushil Finance –

  • Swastika Investmart –

  • Ventura Securities –

  • Geojit –

  • Reliance Securities –

  • Capital Market –

  • BP Wealth –

  • ICICIdirect –

  • Choice Broking –

IPO Lead Managers aka Merchant Bankers

  • Jm Financial Limited

  • Citigroup Global Markets India Private Limited

  • J.P. Morgan India Private Limited

  • Nomura Financial Advisory And Securities (India) Pvt Ltd

Application Lot Size Shares Amount
Retail Minimum 1 26 ₹14,820
Retail Maximum 13 338 ₹1,92,660
S-HNI Minimum 14 364 ₹2,07,480
B-HNI Minimum 68 1,768 ₹10,07,760

IPO Open Date: July 14, 2025
IPO Close Date: July 16, 2025
Basis of Allotment: July 17, 2025
Refunds: July 18, 2025
Credit to Demat Account: July 18, 2025
IPO Listing Date: July 21, 2025

Period Ended Revenue Expense Profit After Tax Assets
2022 ₹1,280.24 ₹734.10 ₹405.54 ₹1,618.87
2023 ₹1,133.99 ₹698.50 ₹385.19 ₹2,014.46
2024 ₹1,483.07 ₹1,005.75 ₹367.31 ₹2,398.11
2025 ₹1,930.29 ₹1,273.42 ₹451.26 ₹2,807.58

KPI Values
ROE: 20.82%
ROCE: 27.64%
EBITDA Margin: 36.81%
PAT Margin: 23.38%
Debt to equity ratio: 0.05
Earning Per Share (EPS): ₹8.07 (Basic)
Price/Earning P/E Ratio: N/A
Return on Net Worth (RoNW): 20.82%
Net Asset Value (NAV): ₹43.10

Company EPS PE Ratio RoNW % NAV Income
Syngene International Limited 12.35 51.54 11.05% 117.42 3,642.40 Cr.
Sai Life Sciences Limited 8.83 92.18 10.96% 102.12 1,694.57 Cr.
Suven Life Sciences Limited 10.52 97.29 13.61% 72.31 1,197.58 Cr.
Divi’s Laboratories Limited 82.53 83.22 15.35% 564.87 9,360.00 Cr.

IPO Open Date: July 14, 2025
IPO Close Date: July 16, 2025
Face Value: ₹2 Per Equity Share
IPO Price Band: ₹540 to ₹570 Per Share
Issue Size: Approx ₹3,395 Crores
Offer for Sale: Approx 5,95,61,404 Equity Shares
Issue Type: Book Build Issue
IPO Listing: BSE & NSE
Retail Quota: Not more than 35%
QIB Quota: Not more than 50%
NII Quota: Not more than 15%
DRHP Draft Prospectus: Click Here
RHP Draft Prospectus: Click Here
Anchor Investors List: Click Here

Disclaimer:Logos and other registered trademarks of funds used on this platform are held by their respective owners. IpoTec does not claim ownership or association on them, and their use is purely for informational and illustrative purposes.

Copyrights ©2025 IpoTec. All rights reserved.